Back

Time-varying cox model for heart failure prediction in phospholamban p.(Arg14del)-positive individuals

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Specific underlying diseases of heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Myrthe Van Der Heide

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Prognostic impact of myocarditis as aetiology compared with dilated cardiomyopathy and ischaemic heart disease in heart failure
Professor M. Fu (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Adverse prognostic implications of increased left ventricular force in hypertrophic cardiomyopathy
Professor K. Wierzbowska-Drabik (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients
Doctor M. Jensen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Clinical and genetic profiles of patients with hereditary and wild type transthyretin amyloidosis: the transthyretin cardiac amyloidosis registry in the state of Sao Paulo, Brazil REACT-SP
Assistant Professor F. Fernandes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Is the incidence of cerebral embolic events underestimated in Takotsubo cardiomyopathy?
Doctor M. Ilinca (Sherbrooke, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Specific underlying diseases of heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Predicting heart failure in phospholamban p.(Arg14del)-positive individuals using vectorcardiographic information
thumbnail
Congress Presentation
New joint model for the dynamic prediction of heart failure in phospholamban (PLN) p.(Arg14del) positive individuals
thumbnail
Congress Presentation
Role of mitral regurgitation in a new predictive model for mortality and hospitalization risk in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources